CFDE Data Portal | Search SPRR1B

	Label	Description
	SPRR1B associations Collection (Entity type)	Associations for SPRR1B_associations
	SPRR1B associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	SPRR1B Gene (Entity type)	ENSG00000169469 - small proline rich protein 1B
	GSE202434 GSE202438 talazoparib 6 v 11 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 1 v 10 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE48812 sulforaphane 8 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE82032 trametinib HCC1143 3 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE48812 8 V 1 SULFORAPHANE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434,GSE202438 6 V 11 TALAZOPARIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE214596,GSE214598 1 V 0 ROSIGLITAZONE MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS

SPRR1B associations

Associations for SPRR1B_associations

SPRR1B associations.tsv

A file from IDG as part of the Harmonizome project

SPRR1B

ENSG00000169469 - small proline rich protein 1B

GSE202434 GSE202438 talazoparib 6 v 11 human up

A Gene Set from LINCS

GSE239844 crizotinib 1 v 10 human dn

A Gene Set from LINCS

GSE48812 sulforaphane 8 v 1 human dn

A Gene Set from LINCS

GSE82032 trametinib HCC1143 3 v 1 human dn

A Gene Set from LINCS

GSE48812 8 V 1 SULFORAPHANE HUMAN DN

A Gene Set from LINCS

GSE202434,GSE202438 6 V 11 TALAZOPARIB HUMAN UP

A Gene Set from LINCS

GSE214596,GSE214598 1 V 0 ROSIGLITAZONE MOUSE UP

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.